Chad Thomas  Campbell net worth and biography

Chad Campbell Biography and Net Worth

Senior Vice President and General Manager, Vascular Access, Chad Campbell joined the AngioDynamics team in May 2016 bringing more than 20 years of sales and marketing experience. Mr. Campbell joined AngioDynamics from Medtronic where he served as the Vice President of Marketing for the Patient Care and Safety business after serving as the Vice President of Marketing for the SharpSafety business at Covidien. During his tenure at Covidien, Campbell also held roles as Director of Marketing, Area Vice President of Sales, Region Manager, Product Manager and Account Manager. Mr. Campbell holds a Bachelor of Arts degree from the University of Kentucky.

How old is Chad Thomas Campbell?

Mr. Campbell is currently 53 years old. There are 7 older executives and no younger executives at AngioDynamics. The oldest executive at AngioDynamics is Mr. James C. Clemmer, CEO, President & Director, who is 60 years old. Learn More on Chad Thomas Campbell's age.

How do I contact Chad Thomas Campbell?

The corporate mailing address for Mr. Campbell and other AngioDynamics executives is 14 PLAZA DRIVE, LATHAM NY, 12110. AngioDynamics can also be reached via phone at (518) 795-1400 and via email at [email protected]. Learn More on Chad Thomas Campbell's contact information.

Has Chad Thomas Campbell been buying or selling shares of AngioDynamics?

Chad Thomas Campbell has not been actively trading shares of AngioDynamics during the last ninety days. Most recently, Chad Thomas Campbell sold 10,748 shares of the business's stock in a transaction on Tuesday, October 5th. The shares were sold at an average price of $27.15, for a transaction totalling $291,808.20. Learn More on Chad Thomas Campbell's trading history.

Who are AngioDynamics' active insiders?

AngioDynamics' insider roster includes Chad Campbell (SVP), Scott Centea (VP), James Clemmer (CEO), James Clemmer (CEO), Dave Helsel (SVP), and Stephen Trowbridge (CFO). Learn More on AngioDynamics' active insiders.

Are insiders buying or selling shares of AngioDynamics?

During the last twelve months, AngioDynamics insiders bought shares 5 times. They purchased a total of 32,568 shares worth more than $202,847.12. The most recent insider tranaction occured on October, 10th when SVP Warren Nighan Jr bought 100 shares worth more than $608.00. Insiders at AngioDynamics own 5.4% of the company. Learn More about insider trades at AngioDynamics.

Information on this page was last updated on 10/10/2024.

Chad Thomas Campbell Insider Trading History at AngioDynamics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/5/2021Sell10,748$27.15$291,808.20View SEC Filing Icon  
See Full Table

Chad Thomas Campbell Buying and Selling Activity at AngioDynamics

This chart shows Chad Thomas Campbell's buying and selling at AngioDynamics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AngioDynamics Company Overview

AngioDynamics logo
AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
Read More

Today's Range

Now: $8.89
Low: $8.52
High: $8.95

50 Day Range

MA: $7.31
Low: $6.22
High: $9.33

2 Week Range

Now: $8.89
Low: $5.26
High: $9.58

Volume

568,028 shs

Average Volume

533,663 shs

Market Capitalization

$361.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.68